Cargando…
Management of HBV Infection During Immunosuppressive Treatment
The literature on hepatitis B virus (HBV) in immunocompromised patients is heterogeneous and refers mainly to the pre-antivirals era. Currently, a rational approach to the problem of hepatitis B in these patients provides for: a) the evaluation of HBV markers and of liver condition in all subjects s...
Autor principal: | Marzano, Alfredo |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Università Cattolica del Sacro Cuore
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3033125/ https://www.ncbi.nlm.nih.gov/pubmed/21415959 http://dx.doi.org/10.4084/MJHID.2009.025 |
Ejemplares similares
-
HBV reactivation under immunosuppressive treatment – a case series
por: Rădulescu, Mihaela, et al.
Publicado: (2014) -
Management of HBV Infection in Liver Transplantation Patients
por: Vierling, John M.
Publicado: (2005) -
Update Treatment for HBV Infection and Persistent Risk for Hepatocellular Carcinoma: Prospect for an HBV Cure
por: Yoo, Joseph, et al.
Publicado: (2018) -
HBsAg Loss as a Treatment Endpoint for Chronic HBV Infection: HBV Cure
por: Moini, Maryam, et al.
Publicado: (2022) -
Electronic Alert System Significantly Increases HBV Screening Rates Before Immunosuppressive Treatments
por: Şeref Köksal, Aydın, et al.
Publicado: (2023)